journal article·2023-07

Microfluidic Templated Stem Cell Spheroid Microneedles for Diabetic Wound Treatment

Xiangyi Wu, Danqing Huang, Ye Xu, Guopu Chen, Yuanjin Zhao

Advanced Materials· Volume 35· Issue 28
Publisher page

Abstract

Abstract Wound dressing patches based on stem cells have demonstrated promising potential in the treatment of diabetic wounds, while their capabilities in the maintenance of cell stemness, effective exchange of cellular substance, and precise targeting of the stem cells remain to be promoted. Here, a novel stem cell spheroid loaded microneedle (MN@SPs) patch is presented using microfluidic templating technology. By leveraging the precise fluid manipulation capabilities of the microfluidic template, stem cell spheroids (SPs) with uniform size can be generated in situ. The resulting SPs exhibit advanced viability and cell functions, as evidenced by the overexpressed genes related to extracellular matrix organization and angiogenesis. By loading these SPs into the microneedles (MNs), the platform enables the precise delivery and exchange of multiple active substances, which contribute to advanced neovascularization, collagen deposition, and tissue reconstruction of diabetic wounds. Overall, this microfluidic‐engineered stem cell therapy platform demonstrates significant promise in promoting wound healing.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Advancements in Transdermal Drug Delivery · Wound Healing and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Burn and Plastic Surgery Institute of Translational Medicine The Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing 210002 China

State Key Laboratory of Bioelectronics School of Biological Science and Medical Engineering Southeast University Nanjing 210096 China

Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine Vision and Brain Health) Wenzhou Institute University of Chinese Academy of Sciences Wenzhou Zhejiang 325001 China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China · Nanjing Medical Science and Technique Development Foundation · Shenzhen Fundamental Research Program

References (50)

Show source-provided references
1. 10.1111/nyas.1356910.1111/nyas.13569 ↗
2. 10.1073/pnas.201626811710.1073/pnas.2016268117 ↗
3. 10.1126/scitranslmed.abe483910.1126/scitranslmed.abe4839 ↗
4. 10.1021/acs.accounts.0c0086410.1021/acs.accounts.0c00864 ↗
5. 10.3390/cells1115228710.3390/cells11152287 ↗
6. 10.3390/cells808078410.3390/cells8080784 ↗
7. 10.1016/j.ejphar.2018.12.01210.1016/j.ejphar.2018.12.012 ↗
8. 10.1016/j.actbio.2017.01.03610.1016/j.actbio.2017.01.036 ↗
9. 10.1002/smll.20180433210.1002/smll.201804332 ↗
10. 10.1002/sctm.17-012910.1002/sctm.17-0129 ↗
11. 10.1186/s13287-019-1165-510.1186/s13287-019-1165-5 ↗
12. 10.2147/IJN.S27565010.2147/IJN.S275650 ↗
13. 10.3390/ijms2204153810.3390/ijms22041538 ↗
14. 10.1016/j.jdermsci.2012.02.00210.1016/j.jdermsci.2012.02.002 ↗
15. 10.3389/fcell.2021.64696710.3389/fcell.2021.646967 ↗
16. Guo Y. · Chem. Eng. J. · 2022 · 437
17. 10.1016/j.addr.2018.12.01410.1016/j.addr.2018.12.014 ↗
18. 10.1016/j.cej.2020.12471510.1016/j.cej.2020.124715 ↗
19. 10.1007/s40820-021-00747-810.1007/s40820-021-00747-8 ↗
20. 10.1002/adfm.20150494310.1002/adfm.201504943 ↗
21. 10.1016/j.actbio.2016.01.03210.1016/j.actbio.2016.01.032 ↗
22. 10.1016/j.scib.2017.09.00610.1016/j.scib.2017.09.006 ↗
23. 10.1007/s11426-018-9340-y10.1007/s11426-018-9340-y ↗
24. 10.3389/fmolb.2020.0003310.3389/fmolb.2020.00033 ↗
25. 10.1016/j.bioactmat.2022.03.03910.1016/j.bioactmat.2022.03.039 ↗
26. 10.1002/adfm.20200008610.1002/adfm.202000086 ↗
27. 10.1002/adhm.20210218010.1002/adhm.202102180 ↗
28. 10.1021/acsami.9b0257810.1021/acsami.9b02578 ↗
29. 10.1021/acsnano.0c0105910.1021/acsnano.0c01059 ↗
30. 10.1016/j.ebiom.2020.10274310.1016/j.ebiom.2020.102743 ↗
31. 10.1021/acs.nanolett.5b0503010.1021/acs.nanolett.5b05030 ↗
32. 10.1073/pnas.201109911710.1073/pnas.2011099117 ↗
33. 10.1002/advs.20210344910.1002/advs.202103449 ↗
34. 10.1021/acsnano.0c0452710.1021/acsnano.0c04527 ↗
35. Lv D. · Oncol. Lett. · 2017 · 14 · 6999
36. 10.3390/cells812162010.3390/cells8121620 ↗
37. 10.1007/s40005-021-00512-410.1007/s40005-021-00512-4 ↗
38. 10.1007/s13346-021-00909-610.1007/s13346-021-00909-6 ↗
39. 10.1002/advs.20190335910.1002/advs.201903359 ↗
40. 10.1002/adbi.20190007610.1002/adbi.201900076 ↗
41. 10.1016/j.mattod.2021.10.00810.1016/j.mattod.2021.10.008 ↗
42. 10.3892/etm.2017.438810.3892/etm.2017.4388 ↗
43. 10.1038/s41368-022-00198-w10.1038/s41368-022-00198-w ↗
44. 10.1016/j.intimp.2019.10594610.1016/j.intimp.2019.105946 ↗
45. 10.1016/j.mce.2004.10.00310.1016/j.mce.2004.10.003 ↗
46. Liu L. · Chin. J. Cancer · 2021 · 28 · 128
47. Mehta V. B. · Groundwater · 2007 · 25 · 253
48. 10.1124/pharmrev.120.00008610.1124/pharmrev.120.000086 ↗
49. 10.3109/10799893.2015.103041210.3109/10799893.2015.1030412 ↗
50. 10.1002/adfm.20220998610.1002/adfm.202209986 ↗